baber/WOPTO huggingface dataset:
Patent AT-E327252-T1 (AT)
Inventor: KAHLERT HELGA
IPC: C12N15/09
Filed: 1998-03-16
Granted: 2006-06-15
Abstract: The invention relates to modified recombinant allergen mutants which can be obtained from recombinant allergens which are derived from allergens which can be obtained by extraction from natural raw materials such as pollen of the species Phleum pratense. While these modified recombinant allergens stimulate lymphocytes from patients who are allergic to pollent to proliferate and synthesize cytokines, they exhibit a markedly diminished ability to bind to the IgE antibodies which are present in the serum of the T lymphocyte donors and to grass pollen allergen-specific IgEs and can therefore be used for a specific, made-to-release allergy therapy.
Patent AT-E251279-T1 (AT)
Inventor: ROMERO MAGARINO ANTONIO
IPC: F16B2/24
Filed: 1998-04-21
Granted: 2003-10-15
Abstract: The fixing system comprises a staple (1) and a pin (15) which is previously fixed to the corresponding accessory (13) to be connected to the staple (1) in order to form an integral assembly to be fixed to the corresponding panel or self-carrier element. The staple (1) has a window (14) at its base through which the pin (15) can be passed through and remains fixed by means of facing and upper edges (11) to which the sides (8) of the staple itself (1) are connected: thereby, it is possible to mount by insertion and clipping of the pin (15) through the staple (1) the integral assembly formed by the staple, the pin and the accessory to the corresponding body of the vehicle in a direct way and without screws. The dismounting can be effected very easily by means of an appropriate tool which is rotationally actuated in order to separate the upper edges (11) and to separate the staple from the pin thereby dismounting the assembly.   <IMAGE>
Patent AT-E285201-T1 (AT)
Inventor: LEGALLOIS SYLVAIN HENRI
IPC: A61C7/06
Filed: 1998-03-23
Granted: 2005-01-15
Abstract: The invention concerns a fixed or floating adjusting system for standard or miniature positioning devices in certain planes of orthodontic therapy capable of being locked in a fixed position by means of the screw (8). More particularly, it concerns the device for enabling the arch (1) of the positioning device and the pins (2) thereof integral with a stop ring (3) to move along the chin cup (4) shaft (5), the stop means delimiting a range of movement and the return system bringing the shaft (5) and the chin cup (4) back to the initial position. The invention also concerns a reverse system, not shown, that causes the chin cup shaft (5) to be integral with the positioning device arch (1) and pin (2) assembly and not with the chin cup (4), and the stop ring (3) to be integral with the chin cup (4) and not with the positioning device arch (1) and its pins (2).
Patent AT-E240013-T1 (AT)
Inventor: SONNENSCHEIN MENASHE
IPC: H04B11/00
Filed: 1998-06-18
Granted: 2003-05-15
Abstract: A personal underwater communication device which comprises: A display; A memory unit for storing a plurality of preset messages, each message being assigned a common message identification code; Means for assigning a unique identification code to each personal device; Means for selecting one of said preset messages, to be transmitted to a receiving device; Means for selecting one or more receiving devices to which a message is to be transmitted; Means for producing a string encoding said message identification code and the identification code of the transmitting device; Means for modulating said string with at least one ultrasound acoustic modulating frequency, thereby to produce a modulated signal; Means for transmitting said modulated signal in water; Means in each device for receiving transmitted ultrasound acoustic modulated signals; Means for demodulating modulated signals which are received by said device, thereby to produce a demodulated string; Means for decoding a message from said demodulated string; and Means for displaying on the display of the receiving device the received message and the identification code of the transmitting device.
Patent AT-E321487-T1 (AT)
Inventor: WINSTON THOMAS R M D
IPC: A61B1/04
Filed: 1998-07-08
Granted: 2006-04-15
Abstract: Guidance systems for guiding a catheter through tissue within a body are described. In one form, the system is implemented in connection with a catheter which includes a catheter body having a optic fibers extending between a first end and a second end thereof. The guidance system is coupled to the catheter body and includes a first optic fiber, a second optic fiber, and a detecting element. The first optic fiber includes a first end and a second end, and is coupled to the catheter body so that the first optic fiber second end is adjacent the catheter second end. The second optic fiber also includes a first end and a second end, and a reference mirror is positioned adjacent the second optic fiber second end. The first optic fiber first end is communicatively coupled to the detecting element and the second optic fiber first end is communicatively coupled to the detecting element. The detecting element is configured to determine interference between a light beam propagating through the first optic fiber and a light beam propagating through the second optic fiber.
Patent AT-E293367-T1 (AT)
Inventor: HAGEMAN ROBERT JOHAN JOSEPH
IPC: A61K31/198
Filed: 1998-07-14
Granted: 2005-05-15
Abstract: An enteral food composition for clinical or dietary use, comprises, in addition to carbohydrates and proteins or their hydrolysates the following components or their nutritional equivalents, per daily dosage: methionine (0.6-7 g), cysteine (0.5-2.5 g), folic acid (0.4-8 mg). pyridoxal (vitamin B6) (3-20 mg), zinc (18-120 mg) and at least 400 kcal energy in the form of carbohydrates. These amount are well above the Recommended Daily Allowance (RDA) values. Further preferred components include lecithin, cyanocobalamine, betaine and magnesium, as well as transsulfuration metabolites, ATP enhancers and antioxidants.
Patent AT-E339176-T1 (AT)
Inventor: FLEURY LYDIE
IPC: A61F15/00
Filed: 1998-07-08
Granted: 2006-10-15
Abstract: A disposable multi-compartment applicator has two receptacle blisters hermetically closed by a film. One of the receptacle blisters may contain a liquid, fluid, cream, or paste element and the other receptacle blister may contain a dry element, pad, compress, or a material having absorption and restitution power. Squeezing one receptacle blister separates part of the film along a zone of weakness to put the liquid element in communication with the dry element, while keeping the device completely hermetic. After the dry element has been in communication with the liquid element, the dry element may be uncovered for first-aid or other use. The applicator may additionally house sticking plaster or a bandage for covering a wound that has been cleaned using the applicator.
Patent AT-E215019-T1 (AT)
Inventor: FRITSCHI MARKUS
IPC: B41M7/00
Filed: 1998-08-24
Granted: 2002-04-15
Abstract: A process for marking compact discs with identfication including attaching a printed we to compact discs supported on a conveyor and then cutting the compact discs from the web along the edges of the compact discs.
Patent AT-E258543-T1 (AT)
Inventor: ORTIZ RAFAEL
IPC: C07D319/06
Filed: 1998-08-28
Granted: 2004-02-15
Abstract: The present invention relates to methods for preparing beta-ketoester fragrance pro-accords from activated acyl units, 1,3-dioxan-4,6-diones and fragrance raw material alcohols. The first step involves contacting an activated acyl unit, preferably an acid chloride, with a 1,3-dioxan-4,6-dione, an example of which is Meldrum's acid, to form a 2-acyl 1,3-dioxan-4,6-dione which is then reacted with a fragrance raw material alcohol to form the final beta-ketoester fragrance pro-accord. The resulting beta-ketoester fragrance pro-accords are suitable for use in laundry detergent, personal care, and other formulations wherein aesthetic fragrance materials are employed.
Patent AT-E287098-T1 (AT)
Inventor: MEADOR JIM D
IPC: G03F7/11
Filed: 1998-09-28
Granted: 2005-01-15
Abstract: Anti-reflective coating compositions having improved etch rate, inter alia, are prepared from certain high molecular weight polymers and copolymers, particularly glycidyl methacrylate with grafted dyes.
Patent AT-E419862-T1 (AT)
Inventor: MARKOVIC SVETOMIR
IPC: A61P35/00
Filed: 1998-11-06
Granted: 2009-01-15
Abstract: Use of an  alpha -interferon composition in the manufacture of a medicament for reducing the recurrence of a resectable malignant tumor is described. Use of an  alpha -interferon composition in the manufacture of a medicament for treating a human patient having a non-resectable malignant tumor also is described. An article of manufacture combines an  alpha -interferon composition within a packaging material and a package label or insert indicating that administration of an immunostimulatory dosage of an  alpha -interferon composition followed by surgical resection of a malignant tumor can be effective for treating a human patient having the malignant tumor.
Patent AT-E269874-T1 (AT)
Inventor: SCHOONBROOD HAROLD
IPC: C08F2/24
Filed: 1998-12-08
Granted: 2004-07-15
Abstract: The invention concerns a method for preparing an aqueous pressure sensitive adhesive (PSA) emulsion with significantly increased shearing resistance, characterised in that it consists, while polymerising into radical aqueous emulsion monomers comprising at least 60 % of styrene and/or butadiene and/or (meth)acrylic esters and/or vinyl esters and/or vinyl nitriles, in using at least an emulsifier consisting of at least a non-ionic or an anionic fatty alcohol derivative, linear or branched, polyalkoxylated. The invention also concerns the use of an emulsifier as defined above for preparing PSA.
Patent AT-E238748-T1 (AT)
IPC: A61H33/00
Filed: 1999-01-28
Granted: 2003-05-15
Abstract: The whirlpool bath basin, with an integrated filter system, has jets to deliver a water/air mixture and at least one recirculating pump (15,20) where both sides are linked to the basin. An external holder (8) has an exchangeable hollow filter cartridge (13), with recessed inlets (6) from the basin interior at least at the minimum water level line. An opening in the base of the basin is linked to the suction side of the recirculating pump by a suction channel (14), which is connected to the interior of the filter cartridge.
Patent AT-E325588-T1 (AT)
Inventor: SHEN HSIN SUN
IPC: A61F2/00
Filed: 1999-07-26
Granted: 2006-06-15
Abstract: Two parallel elastic rods (2) are inserted into the openings (11) on top of the joint element (1) positioned in the ankle area of the artificial shank. The openings are connected with an axial gap (13) which can be adjusted in size by several bolts (15) screwed into the bores (101). The bolts are also used to keep the rods in position. A similar joint element is fixed at the upper end or knee area of the rods.
Patent AT-E256778-T1 (AT)
Inventor: GROSHENS PIERROT
IPC: A41D27/06
Filed: 1999-02-17
Granted: 2004-01-15
Abstract: The garment interlining fabric (1) has a non woven layer (2) reinforced by one or more knitted layers (2) with floating stitches (3) in floats (4) extending over two or more wales (5). The floats (4) are formed in each row (6) of stitches, or one row in two or more. Each float (4) covers two wales (5) or three or four wales or more. The fabric has a number of short wefts, along the line of the floats, and form part of the stitches. The wefts are mono- or multi filaments, smooth or textured, of natural or synthetic or artificial fibers. A second knitted layer, with floating stitches, has the floats covering at least two wales, placed over the first knitted layer. The yarns in the second knitted layer have a composition and/or thickness which is the same as or different from the yarns in the first knitted layer. The floats in the second layer are the same as or differ from those in the first layer. Textured yarns are of unified multi filaments of 1-35 decitex with 6-150 filaments. The non woven layer (2) is of fibers or continuous filaments of natural materials such as wool or cellulose, synthetic or artificial fibers. The fibers or filaments for the non woven layer (2) have a thickness ≥ 1 decitex, or they are micro fibers or micro filaments with a thickness of ≤ 1 decitex. The non woven layer (2) has a weight of 15-100 g/m<2>. The knitted layers have a stitch density of 2-20 stitches/cm. The knitted yarns are treated in a shrinking stage with a stretch of 4-20% after shrinking. The fabric surface is treated with a heat-setting adhesive. The adhesive is deposited in dots, double dots or lines. An Independent claim is included for a manufacturing process where a non woven layer is reinforced with warp knitting to give at least one knitted layer (3) with floating stitches covering at least two wales. The combined fabric (1) is shrunk, and a heat-setting adhesive is applied to at least one surface.
Patent AT-E218187-T1 (AT)
Inventor: NG KA LOK
IPC: B01J19/00
Filed: 1999-06-16
Granted: 2002-06-15
Abstract: A reactor 1 for the processing of a gaseous medium including a cylindrical reactor chamber 2 within which there is a hollow cylindrical bed 11 of active material 12, and the annular space 18, 311 between the outside of the bed of active material and the reactor chamber is arranged to provide an impedance to axial gas flow which increases in the direction of gas flow along the said annular spaces. The gases are constrained to flow through the bed by the tapered wall (Fig 5). In the embodiment the device is a plasma-assisted gas reactor, with co-axial perforated cylindrical electrodes 6 and 7 defining the borders of the active bed.
Patent AT-E446513-T1 (AT)
Inventor: FARMAKOVSKI DMITRI ALEXANDROVICH
IPC: G01N33/53
Filed: 1999-08-24
Granted: 2009-11-15
Abstract: A sensing electrode for use in methods of electrochemical analysis comprising an electrically conducting electrode coated with an electroconductive polymer membrane having immobilised therein or absorbed thereto adaptor molecules avidin, streptavidin, anti-fitc antibodies through which the sensing electrode can be made specific for an analyte under test by the binding of receptors specific for the analyte.
Patent AT-E501676-T1 (AT)
Inventor: ORBAY JORGE
IPC: A61B17/58
Filed: 1999-09-02
Granted: 2011-04-15
Abstract: A fracture fixation system for stabilizing a fracture of a human bone. Said system comprises a fixation pin (512) and an elongate shaft (540). The fixation pin has a proximal end and a distal end. Said fixation pin is sized to snugly fit within the medullary canal of the bone and having a stiffness sufficient to immobilize the fracture and a flexibility sufficient to permit the fixation pin to bend to facilitate insertion into the medullary canal. The elongate shaft has a proximal end, a distal end (550) with means (560) for boring a hole in the bone in a first direction axial with said shaft, an axial pathway and a pin guide comprising a distal laterally exiting bore (571) in said shaft adjacent said distal end of said shaft and communicating with said axial pathway. Said fixation pin and said shaft are adapted such that said fixation pin is axially movable through said axial pathway and the laterally exiting bore for guiding said fixation pin beyond said distal end of said shaft into the medullary canal of the bone at an oblique angle relative to said first direction.
Patent AT-E551356-T1 (AT)
Inventor: SANSON ALAIN
IPC: A61K38/00
Filed: 1999-09-30
Granted: 2012-04-15
Abstract: The present invention relates to a compound having affinity for a negatively charged phospholipid as well as to a detection molecule, to a conjugate and to a pharmaceutical composition comprising said compound. Generally speaking, the compound of the present invention is useful for specific recognition of lipid vectors. It may be used in engineering and in the generation of compound for recognizing and sequestrating of negatively charged lipids, such as phosphatidyl-serine and phosphatidic acid. The chemical structure of the present invention may have the construction (I).
Patent AT-E240310-T1 (AT)
Inventor: MAKINGS LEWIS
IPC: G01N37/00
Filed: 1999-12-10
Granted: 2003-05-15
Abstract: The invention provides a compound, useful as an optical probe or sensor of the activity of at least one cytochrome P450 enzyme, and methods of using the compound to screen candidate drugs, and candidate drugs identified by these methods. The optical probe of the invention is a compound having the generic structure Y-L-Q, wherein Y is selected from the group consisting of Q as herein defined, saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, aryl, substituted aryl, heteroaryl and substituted heteroaryl; L is selected from the group of (-OCR<SUP>2</SUP>H)<SUB>p</SUB>-, wherein for each p, all R<SUP>2 </SUP>are separately selected from the group consisting of a hydrogen atom, saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkenyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>alkynyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, substituted saturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkyl, substituted unsaturated C<SUB>1</SUB>-C<SUB>20 </SUB>cycloalkenyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, and p is a positive integer no greater than twelve; and Q is a chemical moiety that gives rise to optical properties in its hydroxy or hydroxylate, phenol or phenoxide form that are different from the optical properties that arise from its ether form. Most preferably, p is one, R<SUP>2 </SUP>is hydrogen, and Q is the ether form of a phenoxide fluorophore.
Patent DE-1210777-T1 (DE)
Inventor: MESECHER DAVID
IPC: H04W16/28
Filed: 2000-08-17
Abstract: A receiving device comprising circuitry configured to receive a signal including pilot bits transmitted by a plurality of antennas; wherein the received signal includes data for a single user that was combined with different sequences producing a plurality of combined data sequences; wherein antenna-specific weights for the plurality of antennas are applied to each of the combined data sequences and the antenna specific weights are applied to pilot bits added with the combined data sequences; wherein the received signal includes the pilot bits for each of the plurality of antennas; and wherein the pilot bits for each antenna have a different sequence for that antenna; the circuitry is further configured to derive preferred weights for the received signal based on the pilot bits for each antenna; the circuitry is further configured to recover data for the single user from each of the combined data sequences; and the circuitry is further configured to combine data from the recovered data for the single user from each of the different sequences.
Patent DE-19382146-T1 (DE)
Title: Amorphe hochporöse folie mit reduziertem graphenoxid und deren anwendungen
Inventor: GARRIDO ARIZA JOSÉ ANTONIO
IPC: C01B32/198
Filed: 2019-02-27
Abstract: Amorphe reduzierte Graphenoxid-(rGO)-Dünnschicht mit einer Gesamtdicke von 20 nm bis 5 Mikrometer, die Poren aufweist, die einen Durchmesser von gleich oder weniger als 10 nm haben, gemessen durch Steilwinkel-Ring-Dunkelfeld-Rastertransmissionselektronenmikroskopie (HAADF-STEM).
Patent ES-2307463-T1 (ES)
Inventor: CHUNGI SHUBHA
IPC: A61K9/26
Filed: 2002-08-28
Abstract: An orally administrable pharmaceutical formulation is provided that combines, as active agents, a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, aspirin, and optionally at least one of vitamin B6, B12, and folate; the active agents are each present in a unit dose appropriate for once-daily dosing, and at least one of the active agents is contained in a dosage unit within the dosage form that physically separates it from the other active agents. The formulation is provided as a simple and convenient therapy to reduce the risk of cardiovascular events in individuals who are at elevated cardiovascular risk, including individuals who have systemic lupus erythematosus. The formulation is also therapeutic for individuals during or immediately following an occurrence of acute myocardial infarction.
Patent ES-2940586-T1 (ES)
Title: Lámina decorativa, procedimiento para produir una làmina decorativa y procedimiento para decorar un sustrato objetivo
Inventor: LASCH ROMAN
IPC: B42D25/46
Filed: 2020-11-20
Abstract: La invención se refiere a una lámina decorativa, a un método para producir una lámina decorativa ya un método para decorar un sustrato objetivo. La lámina decorativa, en particular la lámina de laminación, la lámina de estampación en frío o la lámina de estampación en caliente, se compone de una película de soporte (42) y una capa de laca total (41), teniendo la película de soporte (42) un espesor en el rango de 3,0 μm a 10,0 micras.  (Traducción automática con Google Translate, sin valor legal)
Patent ES-2041628-T1 (ES)
IPC: G03B15/05
Filed: 1990-02-13
Abstract: A video camera comprises a video camera body and a light module. Structure is provided, integral with the video camera body, for selectively positioning the light module. The light module can be removably connected to the video camera body. <IMAGE>
Patent ES-2026838-T1 (ES)
IPC: C08L55/02
Filed: 1991-01-21
Abstract: Weatherable thermoplastic polymeric compositions are formed by blending weatherable grafted rubber composition with an aliphatic diester selected from the group consisting of dialkoxyalkoxyalkyl diesters and dialkoxydialkoxyalkyl diesters of aliphatic dicarboxylic acids containing 4 to 8 carbon atoms and 0-2% by weight based on the weight of the polyblend of a silicone fluid.
Patent ES-2048133-T1 (ES)
Inventor: SINTOV AMNON
IPC: C08B37/00
Filed: 1991-05-02
Abstract: A colonic delivery system for delivering a drug to the colon is provided. The system comprises a drug in combination with a matrix, wherein the matrix comprises a saccharide-containing polymer. According to the invention, the matrix is resistant to chemical and enzymatic degradation in the stomach and small intestine. The matrix is degraded in the colon by bacterial enzymatic action, and the drug is released. The system is useful for targeting drugs to the colon in order to treat colonic disease. The system is also useful for enteric administration of drugs such as proteins and peptides which are otherwise degraded in the stomach and small intestine.
Patent ES-2138577-T1 (ES)
Title: Procedimiento de realizacion de un piso de filtro para el tratamiento de las aguas.
Inventor: PERRIN DIDIER
IPC: B01D24/22
Filed: 1998-01-27
Abstract: PROCEDIMIENTO DE REALIZACION DE UN FORJADO DE FILTRO PARA EL TRATAMIENTO DE LAS AGUAS QUE COMPRENDE UNA ESTRUCTURA (10) CONSTITUIDA POR VIGAS O POSTES QUE SOPORTAN UNA LOSA (9) PROVISTA DE VARIOS ORIFICIOS DESTINADOS A RECIBIR ALCACHOFAS (11) CARACTERIZADO PORQUE SE REALIZA EL COLADO DEL HORMIGON DE DICHA ESTRUCTURA Y DE LA LOSA DIRECTAMENTE EN EL REVESTIMIENTO DEL FILTRO, OBTENIENDOSE LA CONFORMACION DE DICHA ESTRUCTURA Y DE LA PARTE INFERIOR DE LA LOSA POR UN UNICO MODELO DE ENCOFRADO PERMANENTE.